Combination therapy with amelotеx and compligamv in patients with osteoarthrosis
Objective: to study the efficiency of combined use of CompligamV (a vitamin B complex group) and Amelotex (meloxicam) in the complex treatment of osteoarthrosis (OA). Subjects and methods. Thirty patients (25 women and 5 men) aged 49 to 83 years with a disease history of 2 to 20 years (mean 6.8 year...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2010-12-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/319 |
| _version_ | 1797876863037603840 |
|---|---|
| author | Tatyana Anatolyevna Vygovskaya |
| author_facet | Tatyana Anatolyevna Vygovskaya |
| author_sort | Tatyana Anatolyevna Vygovskaya |
| collection | DOAJ |
| description | Objective: to study the efficiency of combined use of CompligamV (a vitamin B complex group) and Amelotex (meloxicam) in the complex treatment of osteoarthrosis (OA). Subjects and methods. Thirty patients (25 women and 5 men) aged 49 to 83 years with a disease history of 2 to 20 years (mean 6.8 years) mainly with involvement of knee, ankle, and shoulder joints, X-ray stage II-IV disease (after A. Larsen). OA was complicated by reactive synovitis of the knee and ankle joints in 48.3% of the patients. The minimal course of therapy for OA was 15 days: Amelotex (15 mg, intramuscular) and CompligamV were concurrently administered for the first 5 days; CompligamV therapy was continued on the 6th to 15th days. Therapeutic effectiveness was evaluated from clinical changes ranging in 0 to 5 scores by the Oswestry questionnaire (rest pain, movement pain, and limited active and passive movements). A clinical relevant effect was stated when the scores in each section were decreased by 6 scores or more. Furthermore, the data from the health status scale, the pain intensity scale, and the risk for gastrointestinal complications were assessed by the Singh index. Results. There were clinical improvements (reduced signs of arthritis, increased exercise endurance, relieved pain syndrome) during combination therapy with Amelotex and CompligamV. Conclusion. The rapid onset and long duration of the action of combination therapy with Amelotex and CompligamV positively affected the patients' status and could reduce the cost of treatment |
| first_indexed | 2024-04-10T02:08:09Z |
| format | Article |
| id | doaj.art-03953b0e9f9c4dc8a1c34b127de2751a |
| institution | Directory Open Access Journal |
| issn | 1996-7012 2310-158X |
| language | Russian |
| last_indexed | 2024-04-10T02:08:09Z |
| publishDate | 2010-12-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj.art-03953b0e9f9c4dc8a1c34b127de2751a2023-03-13T08:39:21ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2010-12-0144404210.14412/1996-7012-2010-6341624Combination therapy with amelotеx and compligamv in patients with osteoarthrosisTatyana Anatolyevna VygovskayaObjective: to study the efficiency of combined use of CompligamV (a vitamin B complex group) and Amelotex (meloxicam) in the complex treatment of osteoarthrosis (OA). Subjects and methods. Thirty patients (25 women and 5 men) aged 49 to 83 years with a disease history of 2 to 20 years (mean 6.8 years) mainly with involvement of knee, ankle, and shoulder joints, X-ray stage II-IV disease (after A. Larsen). OA was complicated by reactive synovitis of the knee and ankle joints in 48.3% of the patients. The minimal course of therapy for OA was 15 days: Amelotex (15 mg, intramuscular) and CompligamV were concurrently administered for the first 5 days; CompligamV therapy was continued on the 6th to 15th days. Therapeutic effectiveness was evaluated from clinical changes ranging in 0 to 5 scores by the Oswestry questionnaire (rest pain, movement pain, and limited active and passive movements). A clinical relevant effect was stated when the scores in each section were decreased by 6 scores or more. Furthermore, the data from the health status scale, the pain intensity scale, and the risk for gastrointestinal complications were assessed by the Singh index. Results. There were clinical improvements (reduced signs of arthritis, increased exercise endurance, relieved pain syndrome) during combination therapy with Amelotex and CompligamV. Conclusion. The rapid onset and long duration of the action of combination therapy with Amelotex and CompligamV positively affected the patients' status and could reduce the cost of treatmenthttps://mrj.ima-press.net/mrj/article/view/319остеоартрозбольсочетанная терапияамелотекскомплигамв |
| spellingShingle | Tatyana Anatolyevna Vygovskaya Combination therapy with amelotеx and compligamv in patients with osteoarthrosis Современная ревматология остеоартроз боль сочетанная терапия амелотекс комплигамв |
| title | Combination therapy with amelotеx and compligamv in patients with osteoarthrosis |
| title_full | Combination therapy with amelotеx and compligamv in patients with osteoarthrosis |
| title_fullStr | Combination therapy with amelotеx and compligamv in patients with osteoarthrosis |
| title_full_unstemmed | Combination therapy with amelotеx and compligamv in patients with osteoarthrosis |
| title_short | Combination therapy with amelotеx and compligamv in patients with osteoarthrosis |
| title_sort | combination therapy with amelotеx and compligamv in patients with osteoarthrosis |
| topic | остеоартроз боль сочетанная терапия амелотекс комплигамв |
| url | https://mrj.ima-press.net/mrj/article/view/319 |
| work_keys_str_mv | AT tatyanaanatolyevnavygovskaya combinationtherapywithamelotexandcompligamvinpatientswithosteoarthrosis |